Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
Clinical trial NCT00689104 · COMPLETED
Trial details
- NCT number
- NCT00689104
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-28
- Primary completion
- 2009-03-24
- Enrollment
- 2336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.